{"id":"https://openalex.org/W143750840","doi":null,"title":"Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence.","display_name":"Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence.","alternate_titles":[],"publication_year":1993,"publication_date":"1993-01-01","ids":{"openalex":"https://openalex.org/W143750840","mag":"143750840","pmid":"https://pubmed.ncbi.nlm.nih.gov/7910739"},"language":"en","primary_location":{"id":"pmid:7910739","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7910739","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biochemical Society symposium","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W143750840"],"child_works_count":0,"type":"conference-paper","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022878134","display_name":"P. Schoch","orcid":"https://orcid.org/0000-0001-6945-2126","observed_orcids":["https://orcid.org/0000-0001-6945-2126"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P Schoch","raw_affiliation_strings":["F. Hoffmann-La Roche, Pharma Division, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche, Pharma Division, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105275798","display_name":"J L Moreau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J L Moreau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J R Martin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J R Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000376319","display_name":"Willy E. Haefely","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W E Haefely","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":19.25,"has_fulltext":false,"cited_by_count":39,"reviewed_by_count":0,"citation_normalized_percentile":{"value":1.0,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"59","issue":null,"first_page":"121","last_page":"134"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.020800000056624413,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzodiazepine-receptor","display_name":"benzodiazepine receptor","score":0.9869999885559082},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.9419999718666077},{"id":"https://openalex.org/keywords/drug-addiction","display_name":"drug addiction","score":0.8999999761581421},{"id":"https://openalex.org/keywords/receptor-downregulation","display_name":"receptor down-regulation","score":0.8149999976158142},{"id":"https://openalex.org/keywords/partial-agonists","display_name":"partial agonists","score":0.8460000157356262},{"id":"https://openalex.org/keywords/alprazolam","display_name":"alprazolam","score":0.8550000190734863},{"id":"https://openalex.org/keywords/bretazenil","display_name":"bretazenil","score":0.925000011920929},{"id":"https://openalex.org/keywords/zolpidem","display_name":"zolpidem","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lorazepam","display_name":"lorazepam","score":0.9959999918937683},{"id":"https://openalex.org/keywords/withdrawal-reactions","display_name":"withdrawal reactions","score":0.6899999976158142},{"id":"https://openalex.org/keywords/gaba-a-receptor","display_name":"GABAA receptor","score":0.7509999871253967},{"id":"https://openalex.org/keywords/chronic-drug-administration","display_name":"chronic drug administration","score":0.5059999823570251},{"id":"https://openalex.org/keywords/benzodiazepine-receptor-antagonists","display_name":"benzodiazepine antagonists","score":0.6669999957084656}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7424118518829346},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.7231667041778564},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6466583013534546},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.5785335302352905},{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.5612025856971741},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5115845799446106},{"id":"https://openalex.org/C2777123777","wikidata":"https://www.wikidata.org/wiki/Q218842","display_name":"Zolpidem","level":3,"score":0.48229077458381653},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4409659504890442},{"id":"https://openalex.org/C25876315","wikidata":"https://www.wikidata.org/wiki/Q15197465","display_name":"Neurochemical","level":2,"score":0.42706745862960815},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2572636604309082},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22850081324577332},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08635920286178589},{"id":"https://openalex.org/C2781210498","wikidata":"https://www.wikidata.org/wiki/Q1869874","display_name":"Insomnia","level":2,"score":0.08298817276954651}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000882","descriptor_name":"Haplorhini","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:7910739","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7910739","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biochemical Society symposium","raw_type":"Journal Article"},{"id":"mag:143750840","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7910739","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2415377498","https://openalex.org/W2247223595","https://openalex.org/W2243793709","https://openalex.org/W1997210135","https://openalex.org/W113646378","https://openalex.org/W2087836660","https://openalex.org/W3198101455","https://openalex.org/W2041124713","https://openalex.org/W2006069077"],"abstract_inverted_index":{"Potential":[0],"development":[1],"of":[2,17,31,59,71,109,128,172],"tolerance":[3,161],"to":[4,99,116,119,156],"and":[5,20,34,78,125,143,160,188],"dependence":[6,159],"on":[7],"benzodiazepine":[8,25,73,88,120,189],"tranquilizers":[9],"often":[10],"limit":[11],"their":[12,154],"use":[13],"for":[14],"long-term":[15],"treatment":[16],"epilepsy,":[18],"anxiety":[19],"insomnia.":[21],"Current":[22],"developments":[23],"in":[24,65,76,114,123,153],"receptor":[26,35,74,89,121,144,178,190],"pharmacology,":[27],"i.e.":[28],"the":[29,87,169],"advent":[30],"partial":[32,81,142],"agonists":[33,38,147,152],"subtype":[36,145],"specific":[37],"(Fig.":[39],"1),":[40],"however,":[41,94],"might":[42],"eventually":[43],"overcome":[44],"these":[45,173],"limitations,":[46],"thus":[47],"greatly":[48],"improving":[49],"therapeutic":[50],"prospects.":[51],"The":[52,80],"present":[53],"study":[54],"demonstrates":[55],"that":[56,106,141,168],"subchronic":[57,107],"administration":[58],"alprazolam":[60],"(a":[61,111],"high-efficacy":[62,112],"agonist)":[63],"results":[64],"strong":[66],"withdrawal":[67],"reactions":[68],"upon":[69,162],"injection":[70],"a":[72],"antagonist":[75],"mice":[77],"monkeys.":[79],"agonist":[82,92],"bretazenil,":[83],"as":[84,86],"well":[85],"type":[90],"1-preferring":[91],"zolpidem,":[93],"are":[95],"much":[96],"less":[97],"prone":[98],"producing":[100],"such":[101],"reactions.":[102],"Neurochemical":[103],"studies":[104],"showed":[105],"infusion":[108],"lorazepam":[110],"agonist),":[113],"contrast":[115],"betrazenil,":[117],"led":[118],"downregulation":[122,179],"vivo":[124],"reduced":[126,181],"potentiation":[127],"gamma-aminobutyric":[129],"acid":[130],"(GABA)-stimulated":[131],"chloride":[132],"flux":[133],"by":[134],"diazepam":[135],"ex":[136],"vivo.":[137],"These":[138],"findings":[139],"indicate":[140],"1-selective":[146],"differ":[148],"from":[149],"full,":[150],"non-selective":[151],"liability":[155],"induce":[157],"drug":[158],"chronic":[163],"administration.":[164],"It":[165],"is":[166],"hypothesized":[167],"neurochemical":[170],"basis":[171],"adaptive":[174],"phenomena":[175],"may":[176],"be":[177],"and/or":[180],"coupling":[182],"between":[183],"GABAA":[184],"receptor/chloride":[185],"channel":[186],"gating":[187],"binding.":[191]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W143750840","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
